Pembrolizumab alone or in combination with chemotherapy can provide long-term benefits over chemotherapy alone in recurrent or metastatic HNSCC, data suggest.

Angela Goodrich, 45, was shocked to be diagnosed with an extremely rare cancer. She shared her story and symptoms with TODAY.com before she passed away.